Company: BIAF
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023405
Chunk: 17

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 8
Chunk 17
---
 statement. The new disclosure requirements are effective
for the Company’s annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with
early adoption permitted. The Company is currently evaluating the impact of this pronouncement on its related disclosures.

Segment
Information

The
Company is organized into two operating segments, Diagnostic Research and Development (“R&D”) and Laboratory Services,
whereby its chief operating decision maker (“CODM”) assesses the performance of and allocates resources. The CODM is the
Chief Executive Officer. Diagnostic R&D includes research and development and clinical development on diagnostic tests and therapeutic
discoveries. Any revenues assigned to Diagnostic R&D are proceeds received from observational studies. Laboratory services include
all the operations from Village Oaks and PPLS in addition to sales and marketing costs of CyPath® Lung from bioAffinity
Technologies.

SCHEDULE OF SEGMENT INFORMATION 

    2025  
    2024  
    2025  
    2024 

    Three months ended September 30,  
    Nine months ended
                                                                                September 30, 

    2025  
    2024  
    2025  
    2024 
  
    Net revenue: 

    Diagnostic R&D 
    $—  
    $1,731  
    $—  
    $8,654 
  
    Laboratory
services 
     1,446,066  
     2,348,655  
     4,569,146  
     7,145,775 
  
    Total net revenue 
     1,446,066  
     2,350,386  
     4,569,146  
     7,154,429 

    Operating expenses: 

    Diagnostic R&D 
     (473,900) 
     (368,202) 
     (1,420,290) 
     (1,264,696)
  
    Laboratory services 
     (1,509,795) 
     (2,150,825) 
     (5,423,922) 
     (7,423,109)
  
    General corporate activities 
     (1,755,217) 
     (1,805,223) 
     (5,160,479) 
     (4,473,